THE HORMONAL PROFILE IN WOMEN AT HIGH RISK FOR OVARIAN HYPERSTIMULATION SYNDROME AFTER REPLACEMENT OF AN OVULATION TRIGGER
- Authors: MARTAZANOVA B.A1, MISHIEVA N.G1, VEDIKHINA I.A1, AKSENENKO A.A1, EAPEN S.M1, IBRAGIMOVA M.K.1, IVANETS T.Y.1, ABUBAKIROV A.N1
-
Affiliations:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Issue: No 6 (2015)
- Pages: 84-90
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247417
- ID: 247417
Cite item
Abstract
Full Text
About the authors
B. A MARTAZANOVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: bellamart88@mail.ru
graduate student Moscow 117997, Ac. Oparina str. 4, Russia
N. G MISHIEVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@mail.ru
MD, Senior researcher of 1st gynecology department Moscow 117997, Ac. Oparina str. 4, Russia
I. A VEDIKHINA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: i_vedikhina@oparina4.ru
Biologist of the Scientific Diagnostical Laboratory Moscow 117997, Ac. Oparina str. 4, Russia
A. A AKSENENKO
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_axenenko@oparina4.ru
doctor of 1st gynecology department Moscow 117997, Ac. Oparina str. 4, Russia
S. M EAPEN
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: dr.snehaeapen@gmail.com
graduate student Moscow 117997, Ac. Oparina str. 4, Russia
M. Kh IBRAGIMOVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: habibi_m@mail.ru
PhD, doctor of 1st gynecology department Moscow 117997, Ac. Oparina str. 4, Russia
T. Yu IVANETS
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: t_ivanets@oparina4.ru
Head of the Scientific Diagnostical Laboratory Moscow 117997, Ac. Oparina str. 4, Russia
A. N ABUBAKIROV
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@yahoo.com
PhD, Head of 1-st gynecology department Moscow 117997, Ac. Oparina str. 4, Russia
References
- Kessler M.J., Reddy M.S., Shah R.H., Bahl O.P. Structures of N-glycosidiccarbohydrate units of human chorionic gonadotropin. J. Biol. Chem. 1979; 254(16): 7901-8.
- Damewood M.D., Shen W., Zacur H.A., Schlaff W.D., Rock J.A., Wallach E.E. Disappearance of exogenously administered human chorionic gonadotropin. Fertil. Steril. 1989; 52(3): 398-400.
- Sharpless J.L., Supko J.G., Martin K.A., Hall J.E. Disappearance of endogenous luteinizing hormone is prolonged in postmenopausal women. J. Clin. Endocrinol. Metab. 1999; 84(2): 688-94.
- Yen S.S., Llerena O., Little B., Pearson O.H. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J. Clin. Endocrinol. Metab. 1968; 28(12): 1763-7.
- Fauser B.C., de Jong D., Olivennes F., Wramsby H., Tay C., Itskovitz-Eldor J., Van Hooren H.G. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J. Clin. Endocrinol. Metab. 2002; 87(2):709-15.
- Damewood M.D., Shen W., Zacur H.A., Schlaff W.D., Rock J.A., Wallach E.E. Disappearance of exogenously administered human chorionic gonadotropin. Fertil. Steril. 1989; 52(3): 398-400.
- Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil. Steril. 2004; 81(1): 1-5.
- Hoff J.D., Quigley M.E., Yen S.S. Hormonal dynamics at midcycle: a revaluation. J. Clin. Endocrinol. Metab. 1983; 57(4): 792-6.
- ChandrasekherY.A.,Hutchison J.S., Zelinski-Wooten M.B., Hess D.L., Wolf D.P., Stouffer R.L. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge. J. Clin. Endocrinol. Metab. 1994; 79(1): 298-306.
- Itskovitz J., Boldes R., Levron J., Erlik Y., Kahana L., Brandes J.M. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril. 1991; 56(2): 213-20.
- Andersen C.Y., Andersen K.V. Improving the luteal phase after ovarian stimulation: reviewing new options. Reprod. Biomed. Online. 2014; 28(5): 552-9.
- Itskovitz J., Boldes R., Barlev A., Erlik Y., Kahana L., Brandes J.M. The induction of LH surge and oocyte maturation by GnRH analogue (buserelin) in women undergoing ovarian stimulation for in vitro fertilisation. Gynecol. Endocrinol. 1988; 2(Suppl. 2): 165.
- Youssef M.A., Van der Veen F., Al-Inany H.G., Griesinger G., Mochtar M.H., Aboulfoutouh I. et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggeringin antagonist assisted productive technology cycles. Cochrane Database Syst. Rev. 2011; (1): CD008046.
- Acevedo B., Gomez-Palomares J.L., Ricciarelli E., Hernandez E.R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil. Steril. 2006; 86(6): 1682-7.
- Humaidan P., Bredkjaer H.E., Bungum L., Bungum M., Grøndahl M.L., Westergaard L., Andersen C.Y. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum. Reprod. 2005; 20(5): 1213-20.
- Andersen C.Y., Humaidan P., Ejdrup H.B., Bungum L., Grøndahl M.L., Westergaard L.G. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction. Hum. Reprod. 2006; 21(8): 2126-30.
- Leth-Moller K., Hammer Jagd S., Humaidan P. The luteal phase after GnRHa trigger-understanding an enigma. Int. J. Fertil. Steril. 2014; 8(3): 227-34.
- Lee T.H., Liu C.H., Huang C.C., Wu Y.L., Shih Y.T., Ho H.N., Yang Y.S., Lee M.S. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum. Reprod. 2008; 23(1): 160-7.
- Kwee J., Schats R., McDonnell J., Themmen A., de Jong F., Lambalk C. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil. Steril. 2008; 90(3): 737-43.
- Golan A., Ron-El R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv. 1989; 44(6): 430-40.